November 2020 - Page 3 of 3 - PsychedelicNewsWire (PNW)

FridayNov 06, 2020 10:15 am

How Much Does the Public Really Know About Psilocybin?

With various cities such as Santa Cruz, Oakland and Denver having decriminalized psilocybin, and Oregon actually passing a ballot measure legalizing magic mushroom therapy, it’s clear that the many therapeutic benefits of psilocybin demonstrated in research are bearing fruit. While this progress may be hard to deny, a large percentage of Americans have no knowledge about the recent strides that have been made in psilocybin research. A study, which focused on newspaper coverage about psilocybin, analyzed how many times psilocybin was mentioned in four different newspapers between January 1, 1989, and December 31, 2019. The analysis also examined three main…

ThursdayNov 05, 2020 3:00 pm

Why LSD Trips Last Long

The findings of research published in the “Cell” journal have demonstrated that once LSD is consumed, a part of the serotonin receptor allows the compound to perch on the brain for up to 12 hours. LSD, which is a psychedelic, alters an individual’s perception and cognition. The potent drug gained popularity globally during the hippie years in the 1960s and 1970s as a recreational drug. However, as it had a high potential for severe physical and psychological dependency as well as for abuse, it was quickly classified as a Schedule 1 drug. Between 1988 and 1993, the Swiss government allowed…

WednesdayNov 04, 2020 3:45 pm

Researchers Look into Creating Powerful Drugs Free from Undesirable Side Effects

Psychedelics, such as magic mushrooms and LSD, have shown to be extremely effective in treating PTSD and depression. With more states working towards decriminalizing psychedelic substances, we can do more than hope that these drugs will become legal alternative forms of therapy in the near future. However, their use is currently restricted because of the hallucinogenic effect they can cause. So how do we reap the benefits of these compounds while avoiding their unwanted side effects? Ron Dror, an associate professor of computer science from Stanford University, has found an answer. The professor and his research team are currently developing…

TuesdayNov 03, 2020 3:59 pm

Pure Extracts Consolidates Hold on Canada’s Extract Sector; Receives Standard Processing Licence from Health Canada

Pure Extracts Technologies specializes in extraction of key molecules, oils from biomass Extracts are used to manufacture THC & CBD oils, edibles, infused beverages Edible and infused beverage products have been available in Canada since late 2019, taking up 13% market share within Canada’s specialty drug market Pure Extracts recently awarded standard processing license by Health Canada, which will enable the Company to produce clinical trial samples in its purpose-built facilities located near Whistler, Canada Pure Extracts Technologies, a Pemberton, British Columbia-domiciled private plant extraction company, has witnessed its fortunes rise as of late. The Company’s unique business model is…

TuesdayNov 03, 2020 3:50 pm

Rritual Mushrooms, Inc. Is Increasing Awareness of Medicinal Mushrooms and Adaptogenic Herbs

The functional mushroom space has no clear leader, allowing for Rritual to target the role as the only premium brand currently on the market The company’s premium suite of products will be available first online through their website and the Amazon shop Rritual was the runner up for the Buyer’s Choice Award in the virtual ECRM presentation that connects companies with retail establishments creating business relationships The company was chosen for a special ECRM program on October 22, 2020, due to its award-winning status, connecting it to major retailers such as ALDI, Costco, Albertsons/Safeway, and Amazon The current functional food…

TuesdayNov 03, 2020 11:30 am

Oregon Psilocybin Ballot Initiative Can Help Dying Patients Find Peace, Doctor Says in Campaign Advert

In a new TV ad, a medical doctor states that Oregon’s measure to legalize psilocybin therapy has the potential to help alleviate the mental suffering that people who are terminally ill go through. In the short ad, Dr. Nick Gideonse explains that having worked in hospice care for almost three decades, he believes that when people are dying, their pain — whether it is mental or physical — should be treated. Gideonse added that mental suffering often accompanies a terminal prognosis. This is why he supports Measure 109, which allows psilocybin therapy for people who are terminally ill and going…

MondayNov 02, 2020 12:36 pm

CYBIN Corp. Set to Benefit from Growing Research, Interest in Psychedelics

Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre for Psychedelic Science As an innovative company focusing on psilocybin, CYBIN is set to capitalize on growing academic, commercial attention UC Berkeley is joining other prominent academic institutions, including Johns Hopkins University in Maryland and Imperial College in London, to accelerate the scientific research of psilocybin by launching a new center focusing on the compound (https://ibn.fm/CL4wX). As a mushroom life science company that expects to…

MondayNov 02, 2020 10:45 am

Psychedelics Company Makes History as First Firm to Legally Harvest Magic Mushrooms

Numinus (TSX.V: NUMI) has become the first psychedelics company in Canada to legally complete a harvest of magic mushrooms since the 1970s. The healthcare company, which is based in Vancouver, focuses on product development and research. The company harvested its first psilocybin mushrooms last week at its licensed facility in Nanaimo, where it also manages a testing and research laboratory. The company received a license from Health Canada to cultivate and extract magic mushrooms in June and is currently developing solutions and formulations to be used in the rapidly growing psychedelic therapy space. The license, which was issued under the…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: November 2020